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The C. elegans pharynx undergoes elongation and morphogenesis to its characteristic bi-lobed shape between the 2- and 3-fold stages of
embryogenesis. During this period, the pharyngeal muscles and marginal cells forming the isthmus between the anterior and posterior pharyngeal
bulbs elongate and narrow. We have identified the spontaneous mutant pyr-1(cu8) exhibiting defective pharyngeal isthmus elongation,
cytoskeletal organization defects, and maternal effect lethality. pyr-1 encodes CAD, a trifunctional enzyme required for de novo pyrimidine
synthesis, and pyr-1(cu8) mutants are rescued by supplying exogenous pyrimidines. Similar pharyngeal defects and maternal effect lethality were
found in sqv-1, sqv-8, rib-1 and rib-2 mutants, which affect enzymes involved in heparan sulfate proteoglycan (HSPG) synthesis. rib-1 mutant
lethality was enhanced in a pyr-1 mutant background, indicating that HSPG synthesis is very sensitive to decreased pyrimidine pools, and HS
disaccharides are moderately decreased in both rib-1 and pyr-1 mutants. We hypothesize that HSPGs are necessary for pharyngeal isthmus
elongation, and pyr-1 functions upstream of proteoglycan synthesizing enzymes by providing precursors of UDP-sugars essential for HSPG
synthesis.
© 2006 Elsevier Inc. All rights reserved.Keywords: C. elegans; Pharynx; Organ morphogenesis; CAD; de novo pyrimidine synthesis; Proteoglycans; sqv genes; rib genesIntroduction
Organ formation requires both the production of appropriate
cell types and their organization into morphologically correct
structures. The latter of these steps depends on a variety of
processes, including the number and orientation of cell
divisions, changes in cell shape, and cell migration. In the
nematode C. elegans, development of the vulva is the best
characterized example of organ formation (reviewed in Bulik
and Robbins, 2002). Vulval cell fate and an invariant cell
division pattern are induced in the ventral hypodermis in⁎ Corresponding author. Department of Biological Sciences (MC567),
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doi:10.1016/j.ydbio.2006.06.008response to signals from the somatic gonad and signals between
vulval and nonvulval precursor cells. These cells subsequently
form the mature vulva through a morphogenetic program that
includes invagination, cell fusion, and vulval eversion. Recently,
mutations in eight sqv genes have been identified that lead to
defects in vulval invagination and maternal effect lethality
(Herman et al., 1999). The sqv genes have all been molecularly
characterized, and remarkably they all encode enzymes involved
in proteoglycan biosynthesis (Berninsone et al., 2001; Bulik et
al., 2000; Hwang and Horvitz, 2002a,b; Hwang et al., 2003a,b;
Mizuguchi et al., 2003). While many of these genes function in
biosynthesis of both heparan sulfate and chondroitin proteogly-
cans, sqv-5 encodes chondroitin synthase, which strongly
suggests that chondroitin biosynthetic defects underlie the
vulval and embryonic defects in all sqv mutants (Hwang et al.,
2003b; Mizuguchi et al., 2003).
The C. elegans pharynx is another excellent model for organ
formation. The pharynx is a complex neuromuscular organ
located at the anterior of the digestive system. The pharynx
410 D.M. Franks et al. / Developmental Biology 296 (2006) 409–420consists of 80 cells of five distinct types, including muscles,
epithelial cells, neurons, gland cells, and structural cells termed
marginal cells (Albertson and Thomson, 1976; Sulston et al.,
1983). The mature pharynx is a myo-epithelial tube consisting
of an anterior procorpus and two bulbs separated by a narrow
isthmus. The pharynx first forms during embryogenesis as an
ellipsoid primordium of undifferentiated cells. The cells within
this primordium subsequently differentiate, and the pharynx
undergoes striking changes in morphology. Initially, the cells in
the primordium acquire a distinct apical–basal polarity with the
apical surface near the center (Leung et al., 1999). The pharynx
then extends towards the overlying epidermis, forming a tubular
epithelium by the 1-1/2 fold stage (430 min. pfc) (Portereiko
and Mango, 2001; Sulston et al., 1983), and mutants defective
in these early morphogenetic events have been identified (Fay et
al., 2003, 2004; Portereiko et al., 2004). The pharynx then
undergoes elongation and dramatic morphological changes to
form the characteristic bi-lobed shape by the 3-fold stage
(∼500 min pfc) (Sulston et al., 1983). During this period, the
isthmus cells elongate anteriorly to separate the pharyngeal
bulbs (Mörck et al., 2004). Mutants defective in HEX family
homeobox gene pha-2 exhibit defects in isthmus elongation,
but these may arise indirectly by mis-specification of the m5
muscle cells comprising the isthmus (Avery, 1993; Mörck et al.,
2004). Thus, the mechanisms directly controlling these later
morphogenetic events remain unknown.
Here we characterize several mutants sharing common
defects in pharyngeal isthmus elongation and maternal effect
lethality. These mutants are defective in pyr-1, which encodes
the enzyme CAD essential for de novo pyrimidine biosynthesis
(Huang and Graves, 2003), sqv-1 and sqv-8, which encode
UDP-glucuronic acid decarboxylase and glucuronyltransferase
essential for heparan sulfate proteoglycan (HSPG) and chon-
droitin proteoglycan (CPG) biosynthesis (Bulik et al., 2000;
Herman and Horvitz, 1999; Hwang and Horvitz, 2002b), and
rib-1 and rib-2, which encode EXT family glycosyltransferases
specifically involved in HSPG biosynthesis (Kitagawa et al.,
2001; Morio et al., 2003). We hypothesize these enzymes
function in a biochemical pathway to produce sugar nucleotides
and ultimately HSPGs necessary for isthmus elongation.Table 1
Cosmid clones tested for rescue of pyr-1(cu8)
Cosmid a Rescued lines/total lines
M05D6 0/2
T13H5 0/3
C04A6 0/8
F28C6 0/4
T22C8 0/2
D2085 3/5
C46C6 0/4
T01B7 0/5
a The indicated cosmids were tested for rescue of pyr-1(cu8) lethality in
extrachromosomal arrays marked with pRF4[rol-6(su1006)]. Pharyngeal
morphology was examined in lines rescued with D2085.Materials and methods
C. elegans handling and strains
C. elegans were maintained under standard conditions on NGM seeded with
E. coli OP50 (Lewis and Fleming, 1995). To test pyrimidine auxotrophy, NGM
was supplemented with either 0.5% uracil or 0.5% uridine prior to autoclaving.
Mutant homozygotes segregating from the following strains were examined
as described in results: OK286 [ pyr-1(cu8)/pyr-1(cu8)]; OK245 [pyr-1(cu8)
unc-4(e120)/mnC1]; OK485 [dpy-13(e184) rib-1(ok556)/nT1]; OK526 [pyr-1
(cu8) unc-4(e120)/mnC1; dpy-13(e184)rib-1(ok556)/++]; OK486 [rib-2
(tm710)/unc-119(ed3)]; OK530 [pyr-1(cu8) unc-4(e120)/mnC1; Ex(ifa-1::gfp
+unc-119)]; MT7485 [sqv-1(n2820)/nT1]; MT8998 [sqv-1(n2819)/nT1];
MT7479 [sqv-2(n2826)]; MT8638 [sqv-2(n3037)/+]; MT7482 [sqv-3(n2823)/
eT1]; MT8999 [unc-42(e270) sqv-4(n2827)/nT1]; MT9647 [unc-29(e1072)
sqv-5(n3039)/hT2]; MT9352 [sqv-6(n2845)/nT1]; MT7562 [sqv-7(n2839)];
MT7480 [sqv-8(n2825)/mnC1]; MT7483 sqv-8(n2822)/mnC1]; SP174 [sqv-8
(mn63) unc-4(e120)/mnC1]; VC302 [rib-1(ok556)/nT1]; XA4900 [rib-2(qa4900)/qC1]; EC668 [unc-119(ed3); Ex(ifa-1::gfp+unc-119)]. The following
strains were used for pyr-1 deficiency mapping: SP426 [mnDf16/mnC1]; SP636
[unc-4(e120) mnDf 67/mnC1]; SP637 [unc-4(e120) mnDf 68/mnC1]; SP645
[mnDf63/mnC1]; SP803 [unc-4(e120) mnDf105/mnC1] (Sigurdson et al., 1984).
Representative rib-1(ok556) homozygotes were verified by single worm
PCR as described previously (Beaster-Jones and Okkema, 2004) using primers
PO607 (CAAATTCGGTCGTTTCGTGC), PO608 (ACAACACATCGGCA-
CATCGTC), and PO609 (CAGAAGGTCGAGTTGGCAAGC).
Strains bearing the pyr-1::gfp transgene were obtained by co-injecting
pOK180.16 (6 μg/ml) and pRF4 (100 μg/ml) (Mello and Fire, 1995).
Isolation, mapping, and rescue of pyr-1(cu8)
pyr-1(cu8) was isolated as a spontaneous mutant and was mapped to LGII
between dpy-10 and unc-4 using standard linkage analysis and 3-factor
mapping (Brenner, 1974). It was localized between zyg-9 and rol-6 by testing
chromosomal deficiencies for complementation of the maternal effect lethal
(Mel) phenotype (Sigurdson et al., 1984). The deficiencies mnDf105 and
mnDf16 complemented pyr-1(cu8), while mnDf63 and mnDf68 failed to
complement pyr-1(cu8). mnDf67 partially complemented pyr-(cu8) and may
break near the pyr-1 gene.
Cosmids between zyg-9 and rol-6 were tested for rescue of pyr-1(cu8) Mel
phenotype and pharyngeal and tail defects (Table 1) by microinjection (5–25 μg/
ml) with pRF4 (100 μg/ml) into unc-4(e120) pyr-1(cu8)/mnC1 and examining
the progeny of transgenic unc-4(120) pyr-1(cu8) homozygotes (Mello and Fire,
1995). Plasmid subclones or PCR fragments of D2085 were similarly tested for
rescue by microinjection into unc-4(e120) pyr-1(cu8)/mnC1 or pyr-1(cu8)/pyr-
1(cu8) and examining progeny of mutant homozygotes. A PCR fragment
rescuing pyr-1(cu8) was amplified from D2085 with primers PO504
(CCACACATCCAACTCTACAAATCCC) and PO505 (CAACCAAAGC-
GATGGTAAGTC) using Elongase Enzyme Mix (Invitrogen), digested with
BssHII, and gel purified prior to microinjection. A similarly prepared PCR
fragment lacking the D2085.1 coding sequence amplified using PO516
(GCTGTCGAAATCGAACTTCTGTG) and PO517 (CCCACAAAAGTG-
GACCCGTC) failed to rescue pyr-1(cu8).
pyr-1(cu8) was sequenced from genomic DNA amplified in ∼3 kb
fragments using primer pairs PO516 (GCTGTCGAAATCGAACTTCTGTG)/
PO517 (CCCACAAAAGTGGACCCGTC), PO518 (GAAATGTTCTTC-
CAGTTTGGTTCG)/PO519 (GATCAATACGTGTCAGCTCGTGAG),
PO520 (TCAGAAGGCGTTGAGAATGGTG)/PO521 (GAGGAAAAGAT-
GATGTGGGCAGAC), and PO522 (CGAGAAGCAAACACTTGCCG)/
PO523 (CGATCTCCATCATAGTGCTCGC). Multiple PCR reactions were
pooled and sequenced with gene specific primers. Regions containing changes
from the D2085 sequence (accession Z54284) were similarly amplified and
sequenced from N2 genomic DNA and D2085 cosmid.
pyr-1(RNAi) analysis
RNAi analyses were performed essentially as previously described (Fire et
al., 1998). dsRNAs produced by in vitro transcription (Ambion) were injected at
approximately 200–500 ng/μl into the germline of young adult N2
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freshly seeded plates. Phenotypes were scored in F1 progeny. The template for
RNA synthesis was yk96d3/pOK169.05 (kindly provided by Y. Kohara).
Measurement of pharyngeal isthmus length
Wild-type or pyr-1(cu8) homozygous L4 hermaphrodites were chosen at
random and photographed using DIC optics. Isthmus length and width were
measured in digital images using AxioVision 3.1.2. The isthmus length was
defined as the distance between the metacorpus/isthmus boundary and the
grinder to facilitate measuring grossly abnormal pyr-1 mutants. Width was
measured at the middle of the isthmus. A Student's t test was conducted to
evaluate the statistical significance of the calculated averages, and a P value for
the two sets of data was determined using Microsoft Excel.
Phalloidin and antibody staining
Actin filaments were visualized using Alexa 488-labeled phalloidin
(Molecular Probes) (Praitis et al., 2005). Intermediate filaments were visualized
in freeze crack permeabilized worms (Miller and Shakes, 1995) by indirect
immunofluorescence using the antibody MH4 (Francis and Waterston, 1985).
Plasmid construction
The pyr-1::gfp containing plasmid pOK180.16 was constructed by inserting
an EcoRV–XbaI fragment (bp 7832–11,583 of cosmid D2085) into the StuI–
NheI sites upstream of a gfp::his2B cassette in pOK176.03. This fragment
contains ∼2.9 kb upstream of the pyr-1 translation start site and is fused in-
frame to gfp::his2B in pyr-1 exon 3, and it encodes PYR-1 residues 1–263. The
gfp::his2B reporter was described previously (Gaudet and Mango, 2002), and it
encodes a nuclear localized GFP protein to facilitate cell identification.
GAG analysis
For GAG analysis, large populations of N2 and VC302 worms were grown
in liquid culture in S media supplemented with E. coli HB101 (Lewis and
Fleming, 1995), while OK286 was grown on standard NGM plates. Worms were
harvested, rinsed with water, and lyophilized. GAGs were prepared and
analyzed from dried homogenates of N2, OK286, or VC302 (dry weight, 8700,Fig. 1. pyr-1(cu8) adult phenotypes. Wild-type (left column) and maternally deplete
anterior region of the adult gut (E, F) indicating an expanded pseudocoelom characte
bulb); tb indicates the terminal bulb. Scale bars indicate 20 μm.5924, and 8411 mg, respectively) as previously described (Mizuguchi et al.,
2003; Yamada et al., 1999). GAG chains were released from the proteoglycan
core proteins by sodium borohydride treatment. As the amount of heparan
sulfate (HS) in C. elegans is small (Mizuguchi et al., 2003), 100 μg of shark
cartilage chondroitin 6-O-sulfate (Seikagaku) containing a negligible proportion
of nonsulfated disaccharides was added as a carrier after the borohydride
treatment but before the purification steps. The unsaturated disaccharides
produced by enzymatic digestion with chondroitinase ABC or a mixture of
heparitinases I and II were derivatized with 2-aminobenzamide and analyzed by
high performance liquid chromatography (Kinoshita and Sugahara, 1999).Results
pyr-1(cu8) results in defective pharyngeal morphology and
maternal effect lethality
We have identified the spontaneous C. elegans mutant pyr-1
(cu8) exhibiting partially penetrant maternal effect lethality and
defects in pharyngeal morphogenesis (pyr for pyrimidine
biosynthesis, see below). pyr-1(cu8) mutants can be maintained
as a homozygous strain producing approximately 95% late-
stage arrested embryos and 5% viable progeny that escape
embryonic lethality. Most of these viable mutants developed to
fertile adults but had an incompletely elongated pharyngeal
isthmus that was shorter and thicker than in wild-type animals
(Figs. 1A, B) [isthmus length: wild-type L4 = 42.04 ± 3.12 μm
(n = 27), pyr-1(cu8) L4 = 35.08 ± 5.94 μm (n = 36)
(P < 0.001)]. While the isthmus length varied in these animals,
39% of pyr-1(cu8) mutants had an isthmus shorter than any of
those observed in wild-type. In comparison, other regions of the
pharynx appeared morphologically normal. The pyr-1(cu8)
phenotype appeared distinct from that of pha-2 mutants (Avery,
1993; Mörck et al., 2004), as mis-positioned nuclei were not
observed in the pyr-1(cu8) isthmus (data not shown). Outside of
the pharynx, viable pyr-1(cu8) mutants exhibited wild-typed pyr-1(cu8) mutant (right column) adult pharynx (A, B), larval tail (C, D), and
ristic of the Clr phenotype (arrowheads). mc indicates the metacorpus (anterior
Fig. 2. pyr-1(cu8) and pyr-1(RNAi) embryonic phenotypes. (A–D) Wild-type
(left) and pyr-1(cu8) (right) 2-fold embryos (A, C) 3-fold embryos (B, D). The
pharynx is outlined for clarity (dashed line). mc indicates the metacorpus; tb
indicates the terminal bulb. (E, F) Pharynx of wild-type L1 (E) and arrested pyr-1
(RNAi) L1 (F). Note the incompletely elongated pharyngeal isthmus in panels D
and F.
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these animals had an abnormally knobbed tail (Figs. 1C, D).
Viable pyr-1(cu8) mutants grew slightly slowly, reaching
adulthood 1 day later than wild-type animals, and many of
them exhibited a mild egg-laying defective (Egl) phenotype. In
addition, 26% of viable pyr-1(cu8) animals exhibited a
moderate clear (Clr) phenotype with space between the gut
and overlying body wall (Figs. 1E, F), which is similar to
mutants with hyperactive FGF signaling (Huang and Stern,
2004; Kokel et al., 1998).
The defects in pharyngeal isthmus elongation and tail
morphology were also apparent in arrested pyr-1(cu8) mutant
embryos. During normal embryogenesis, the pharynx elongates
from a compact cylinder to its recognizable bi-lobed morphol-
ogy during a 1 h period between 430 min and 490 min post first
cleavage (pfc), and this process is coincident with body
elongation from the 1.5-fold to early 3-fold embryo (Sulston et
al., 1983). Arrested pyr-1(cu8) mutant embryos were normally
enclosed in the hypodermis, and 70% underwent complete body
elongation (n > 100); however, many of them displayed an
incompletely elongated isthmus (Figs. 2B, D). The pyr-1(cu8)
mutant pharynx appeared normal through the 2-fold stage
(450 min pfc) (Figs. 2A, C), indicating pyr-1(cu8) specifically
affected late stages of pharyngeal morphogenesis.
pyr-1(cu8) lethality and morphological defects are recessive
maternal effect phenotypes. All progeny segregating from pyr-1
(cu8)/+ hermaphrodites hatched and had normal pharyngeal and
tail morphology (n > 100), but 25% of these progeny (n = 68)
produced mostly arrested embryos and were pyr-1(cu8) homo-
zygotes. Cross progeny of pyr-1(cu8) homozygous hermaphro-
dites and wild-type males were viable and morphologically
normal, indicating either maternal or zygotic pyr-1 expression
was sufficient for viability and pharyngeal morphology.
pyr-1(cu8) is likely not a null allele but appears to be a strong
hypomorph. Embryonic lethality was weakly temperature
sensitive, such that homozygous mutant hermaphrodites raised
at 16°, 20°, and 25° produce 85% (n = 596), 94% (n = 649), and
99% (n = 534) arrested self progeny, respectively. Likewise,
pyr-1(cu8) exhibited partially penetrant zygotic lethality when
placed in trans to the chromosomal deficiencies mnDf63 and
mnDf67 that remove pyr-1. However, the viable pyr-1(cu8)/
mnDf63 hermaphrodites we found produced some progeny
indistinguishable from those of pyr-1(cu8) homozygotes,
suggesting that the maternal effect lethal phenotype of pyr-1
(cu8) was not strongly enhanced in trans to the deficiency (data
not shown). In addition, pyr-1(RNAi) experiments discussed
below did not produce an earlier arrest, consistent with pyr-1
(cu8) causing strong loss-of-function.
pyr-1 encodes C. elegans CAD and is required for pyrimidine
synthesis
We identified pyr-1 as the gene D2085.1 using positional
cloning/transformation rescue and RNAi (see Materials and
methods). pyr-1(cu8) mapped between zyg-9 and rol-6 on
LGII, and transformation with the cosmid D2085 from this
region rescued pyr-1(cu8) lethality and pharyngeal defects in 3of 5 independent lines (Table 1). D2085 contains 7 genes, and
we found transformation with a 10.3 kb fragment containing the
upstream region and 11 of the 12 D2085.1 exons [bases 7129–
17428, numbered according to the D2085 sequence (accession
number Z54284)] rescued pyr-1(cu8) in 12 of 12 independent
lines (Fig. 3A). This fragment lacked the last D2085.1 exon, as
well as the 3′-UTR and poly adenylation signal, indicating that
these sequences are not essential for rescuing activity.
Transformation with only the D2085.1 upstream sequences
failed to rescue, suggesting that rescue required D2085.1
coding sequences. D2085.1(RNAi) resulted in 21% of the
progeny arresting as embryos and 33% exhibiting L1 arrest or
slow growth (n = 5046). Thirty-six percent of arrested D2085.1
(RNAi) L1s exhibited incomplete pharyngeal isthmus elonga-
tion similar to pyr-1(cu8) (n = 50) (Figs. 2E, F). In addition,
36% of these L1s arrested with the pharynx detached form the
buccal cavity (Pun phenotype) (n = 50) or a characteristic bulge
on the head that was not observed in pyr-1(cu8). To confirm that
pyr-1 was D2085.1, we sequenced the entire D2085.1 genomic
Fig. 3. pyr-1 encodes CAD. (A) Schematic diagram of cosmid D2085 showing the extent of each of the genes on this cosmid (arrows on and above line) and the exons
of D2085.1 (arrows below line). Fragments containing each of these genes were tested for rescue of pyr-1(cu8), and the fragment that rescued pyr-1(cu8) is indicated.
(B) The enzymatic domains of PYR-1 based on alignment with the hamster CAD (Huang and Graves, 2003). GLN, glutaminase domain; CPS-A and CPS-B, tandem
carbamoyl phosphate synthetase domains; DHO, dihydroorotase domain; and ATC, aspartate transcarbamoylase domain. The position of the H1602Q change in pyr-1
(cu8) is indicated. (C) ClustalW alignment of the PYR-1 DHO region affected by cu8 with hamster CAD (accession P08955), human CAD (NP_004332), and
Drosophila rudimentary (P05990). The conserved residue altered by pyr-1(cu8) is indicated by an arrowhead.
Table 2
pyr-1(cu8) lethality is rescued by exogenous uracil and uridine
Growth medium % Viable animals (n) a
pyr-1(cu8) Wild type N2
NGM 0.4 (534) 94 (1039)
NGM + uracil b 45 (2062) 94 (325)
NGM + uridineb 29 (1605) 84 (299)
a n = the number of embryos examined under each condition. pyr-1(cu8) or
N2 hermaphrodites was allowed to lay eggs at 25° and removed. The number of
total embryos was counted and the plates were examined the following day to
determine the number of viable animals.
b Uracil or uridine was dissolved at 0.5% in standard NGM plates, and these
were seeded with E. coli OP50 (Lewis and Fleming, 1995).
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and found pyr-1(cu8) resulted from a single C to A substitution
at position 16044 of D2085. A second C to A change from the
D2085 sequence was found at position 14730, but this change
was also found when we resequenced both N2 genomic DNA
and the D2085 cosmid and likely was a miscalled base in
original sequence. Together these results indicate pyr-1(cu8)
affects D2085.1.
pyr-1 encodes C. elegans CAD (carbamoyl phosphate
synthetase, aspartate transcarbamoylase, and dihydroorotase),
a single polypeptide containing 3 enzymes catalyzing rate-
limiting steps in de novo pyrimidine biosynthesis (Huang and
Graves, 2003) (Fig. 3B). PYR-1 is similar to eukaryotic CADs
throughout its entire length and is 56% identical to human CAD
(Iwahana et al., 1996). pyr-1(cu8) is a missense mutation
substituting glutamine for a conserved histidine (residue 1602)
in the dihydroorotase (DHO) domain (Figs. 3B, C). The
corresponding residue in hamster CAD (H1590) is required for
DHO activity and effective binding of Zn2+ participating in
catalysis (Zimmermann et al., 1995). Thus, pyr-1(cu8) mutant
CAD likely lacks DHO activity but retains carbamoyl phosphate
synthetase (CPS) and aspartate transcarbamoylase (ATC)
activities. This hypothesis is consistent with the fact that pyr-1
(cu8)mutants can be rescued with a fragment encoding CPS and
DHO but not ATC (Fig. 3B; residues 1–2033). In Drosophila
melanogaster, CAD is encoded by the classically identified gene
rudimentary (r), and, like pyr-1(cu8), rmutants exhibit a variety
of defects, including morphological defects and maternal effect
lethality (Falk, 1977; Fausto-Sterling and Hsieh, 1976; Rawls
and Fristrom, 1975; Segraves et al., 1984). CAD is essential for
de novo pyrimidine biosynthesis, and the end product of this
pathway is UMP (Huang and Graves, 2003). UMP can also besynthesized from pyrimidines via a salvage pathway, and Dro-
sophila r mutants can be rescued by supplying exogenous
pyrimidines in the media (Falk, 1977; Norby, 1970). We
likewise found that the lethal phenotype of pyr-1(cu8) mutants
was partially rescued by addition of excess uracil or uridine to
the media (Table 2). Thus, pyr-1(cu8) mutant lethality results
from insufficient pyrimidine synthesis rather than build up of
precursors.
The partial maternal effect lethal phenotype of pyr-1(cu8)
mutants suggests that this gene is expressed both in the maternal
germ line and the zygote, and indeed strong mRNA expression
is detected in the germ line of L4 and adult hermaphrodites by in
situ hybridization (Kohara, 2001). We examined expression of a
pyr-1::gfp reporter in transgenic C. elegans (see Materials and
methods). In many cases, expression of such transgenes is
silenced in the maternal germ line, and their expression reflects
zygotic gene expression (Kelly et al., 1997). We found that pyr-
1::gfp was expressed in all cells of the embryo beginning during
Fig. 5. Pharyngeal muscle actin in pyr-1(cu8) and rib-1(ok556) mutants.
Fluorescence micrographs of wild-type (A), pyr-1(cu8) (B), and rib-1(ok556)
(C) larval pharynxes stained with Alexa 488-labeled phalloidin to detect actin
filaments. Anterior is left, and arrowheads indicate the position of the
pharyngeal isthmus. Note that the actin filaments are disrupted throughout the
pharynx in panels B and C. Similarly disorganized actin filaments were
observed in rib-2 mutants.
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(the 4E stage; approximately 115–185 min. pfc) (Figs. 4A, B).
Strong GFP expression continued in the gut until the bean stage
(approximately 350–390 min. post first cleavage), but progres-
sively declined in other cell types (data not shown). pyr-1::gfp
expression was undetectable in later stage embryos but
reappeared in the gut after hatching in L1 larvae through adults
(Fig. 4C). This pattern of widespread expression in the embryo
and gut expression in larvae is consistent with in situ
hybridization results (Kohara, 2001). Mammalian CAD activity
and gene transcription are up-regulated in proliferating cells to
increase pyrimidine nucleotide pools (Huang and Graves,
2003). C. elegans pyr-1 may be similarly regulated to produce
pyrimidine nucleotides during embryonic cleavages and in
larval intestinal cells, which undergo massive DNA endoredu-
plication in each larval stage (Hedgecock and White, 1985).
pyr-1(cu8) mutants have defects in the pharyngeal cytoskeleton
The pharyngeal isthmus consists primarily of muscles and
marginal cells, which contain abundant actin filaments and
intermediate filaments, respectively (Albertson and Thomson,
1976). We examined these cytoskeletal components and found
that both were disorganized in maternally depleted pyr-1(cu8)
animals. In wild-type animals, actin detected by phalloidin
staining was organized in fine filaments extending radially
between the lumenal and basal surfaces of the muscles (Fig. 5A).
In comparison, actin filaments in pyr-1(cu8) mutants appeared
as thick needles that often clumped near the surface of
pharyngeal cells (Fig. 5B). This disorganization extended the
length of the pharynx, and it was apparent in both severely and
mildly affected pyr-1(cu8) mutants. Intermediate filaments in
wild-type and maternally rescued pyr-1(cu8) marginal cells
were evenly spaced and radially oriented when detected in fixed
samples using the antibody MH4 (Fig. 6A) and in live animalsFig. 4. pyr-1::gfp expression. (A, B) Fluorescence (A) and DIC (B) micrographs
of a transgenic 4E-cell stage embryo (approximately 50 cell stage) expressing
pyr-1::gfp. Expression is strongest in the intestinal precursors (arrowheads).
Embryonic expression ends at the bean stage as body morphogenesis begins. (C)
Transgenic L1 larva expressing pyr-1::gfp in the gut. Expression continues in
this tissue through adulthood. ph indicates the pharynx.using a GFP-tagged intermediate filament protein (Fig. 6D)
(Francis and Waterston, 1991; Karabinos et al., 2003). In
contrast, intermediate filaments in pyr-1(cu8) mutants detected
using MH4 were disorganized in the isthmus (Fig. 6B), while
those visualized with GFP-tagged intermediate filament proteins
were of uneven lengths and inappropriately oriented towards the
posterior (Fig. 6E). Notably, intermediate filament disorganiza-
tion was confined to the pharyngeal isthmus and was most
apparent in animals exhibiting isthmus elongation defects.
Mutants defective in proteoglycan synthesis exhibit pharyngeal
defects similar to pyr-1(cu8)
One major use of pyrimidines is in the form of nucleotide
sugars for synthesis of glycoproteins (Bulter and Elling, 1999).
Proteoglycans are an abundant form of glycoprotein found on
cell surfaces and in basement membranes, and the proteoglycan
UNC-52/perlecan accumulates in the pharyngeal basement
membrane coincident with isthmus elongation (Mullen et al.,
1999).
Recently, C. elegans mutants affecting eight sqv genes
encoding enzymes involved in proteoglycan synthesis have been
found to cause defects in vulval morphogenesis and maternal
effect lethality (Herman et al., 1999). We reasoned that if the
pyr-1(cu8) pharyngeal phenotype results from defective pro-
teoglycan synthesis, some sqv mutants would exhibit similar
pharyngeal isthmus elongation defects. We examined mutants
defective in all 8 sqv genes and found maternally depleted sqv-1
(n2820), sqv-8(n2825), and sqv-8(mn63) arrested larvae had
Fig. 6. Pharyngeal marginal cell intermediate filaments in pyr-1(cu8) and rib-1(ok556). Fluorescence micrographs of wild-type (A), pyr-1(cu8) (B), and rib-1(ok556)
(C) 3-fold embryos stained with MAb MH4 to detect intermediate filaments (Francis and Waterston, 1991). Intermediate filaments in the isthmus (arrowhead) are
poorly organized in panels B and C, whereas they are normally organized in the procorpus (arrow). (D, E) Fluorescence micrographs of wild-type (D) and pyr-1(cu8)
(E) larvae bearing an ifa-1::gfp transgene encoding a functional intermediate filament::GFP fusion protein (Karabinos et al., 2003). Isthmus intermediate filaments
(white bracket) are of uniform length and orthogonally oriented to the pharyngeal lumen in panel D, whereas they are of variable length and orientation in panel E.
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pyr-1(cu8) worms (Figs. 7A, B; Table 3). Most other strong
sqv mutants produce maternally depleted progeny that arrest
very early (Herman et al., 1999), and their pharyngeal phenotype
could not be scored. However, maternally depleted sqv-2
(n3037) and sqv-7(n2844) larvae were obtained and exhibited
normal pharyngeal morphology (Table 3). As in pyr-1(cu8), the
pharyngeal defect in sqv-1 and sqv-8 mutants was a maternalFig. 7. Pharyngeal defects in mutants defective in proteoglycan synthesis. DIC microg
rib-1(ok556) (C), rib-2(qa4900) (D), and pyr-1(cu8) unc-4(e120); dpy-13(e184) rib
outlined (dashed line) for clarity. mc indicates the metacorpus; tb indicates the termeffect phenotype. All maternally rescued sqv mutants produced
by heterozygous hermaphrodites exhibited normal pharyngeal
morphology (Table 3). In comparisons to the sqv mutants, pyr-1
(cu8) animals displayed normal vulval morphogenesis (data not
shown). Thus, maternal activity of both PYR-1 and proteoglycan
synthesis enzymes is necessary for pharyngeal isthmus elonga-
tion, whereas zygotic PYR-1 activity is not required for vulval
morphogenesis.raphs of maternally depleted sqv-1(n2820) (A), sqv-8(n2825) (B), dpy-13(e184)
-1(ok556) (E) mutant larvae that have elongated and hatched. The pharynx is
inal bulb.
Table 3
Pharyngeal phenotypes of proteoglycan synthesis defective mutants
Mutant m+, z− pharyngeal
phenotype a
m−, z− pharyngeal
phenotype (n) b, c
sqv-1(n2819) wt n.d. e
sqv-1(n2820) wt Short, thick isthmus (5/14)
sqv-2(n3037) wt wt (0/80)
sqv-2(n2826) n.d. d wt (0/13)
sqv-3(n2823) wt n.d.
sqv-4(n2827) wt n.d.
sqv-5(n3039) wt n.d.
sqv-6(n2845) wt n.d.
sqv-7(n2839) n.d.d wt (0/25)
sqv-7(n2844) wt wt (0/4)
sqv-8(n2825) wt Short, thick isthmus (7/26)
sqv-8(mn63) wt Short, thick isthmus (8/11)
sqv-8(n2822) wt n.d.
rib-1(ok556) wt Short, thick isthmus (16/28)
rib-2(qa4900) wt Short, thick isthmus (10/18)
pyr-1(cu8) wt Short, thick isthmus (9/20)
n.d. = not determined.
a Mutant homozygotes segregating from heterozygous hermaphrodites.
b sqv mutant homozygotes segregating from homozygous hermaphrodites.
c n = number with short, thick isthmus/number of larvae examined.
d Weak alleles that are viable as homozygotes, and the m+, z− phenotypes
were not examined.
e m−, z− progeny arrest prior to pharyngeal elongation (Herman et al., 1999),
and their pharyngeal phenotype could not be determined.
Table 4
pyr-1(cu8) enhances rib-1(ok556) embryonic lethality
Maternal
genotype (n) a, b
% Unenclosed % Elongation
defective
% 3-fold or
arrested larvae
rib-1(ok556) (37) 24 57 19
pyr-1(cu8) (116) 0 21 79
pyr-1(cu8); rib-1
(ok556)/+ (134)
27 54 19
pyr-1(cu8); rib-1
(ok556) (91)
43 37 22
a These experiments were done using pyr-1(cu8) unc-4(e120) II and dpy-13
(e184) rib-1(ok556) IV marked chromosomes, but the markers are not shown in
the maternal genotype for clarity.
b n = total number of self-progeny scored from hermaphrodites of the
indicated genotype.
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tetrasaccharide linker that attaches both chondroitin and
heparan sulfate glycosaminoglycan chains to proteoglycan
proteins (Bulik et al., 2000; Herman and Horvitz, 1999;
Hwang and Horvitz, 2002b), and the pharyngeal defects in
these mutants might result from defective synthesis of either or
both of these proteoglycan classes. In CPGs, this linker is
extended by SQV-5 chondroitin sulfate synthase (Hwang et al.,
2003b; Mizuguchi et al., 2003), whereas in HSPGs, it is
believed to be extended by the RIB-1 and RIB-2 glycosyl-
transferases (Kitagawa et al., 2001; Morio et al., 2003). CPGs
are required in very early development, and sqv-5 depleted
embryos arrest at the first embryonic cleavage making it
impossible to examine their pharyngeal phenotype (Hwang et
al., 2003b; Mizuguchi et al., 2003). In contrast, HSPGs are
required later in embryogenesis, as rib-2(qa4900) and rib-2
(tm710) mutants exhibit maternal effect arrest as late embryos or
early larvae (Morio et al., 2003; Franks and Okkema,
unpublished). Likewise, we have found that the newly isolated
rib-1(ok556) mutant (kindly provided by the C. elegans gene
knockout consortium) is a maternal effect lethal mutant.
Maternally depleted rib-1(ok556) arrested embryos exhibited
late embryonic arrest and body elongation defects similar to
pyr-1(cu8) mutants (Table 4). In addition, ∼25% of rib-1
(ok556) failed in hypodermal enclosure, a phenotype we have
not observed in pyr-1(cu8) single mutants. This lethality was
zygotically rescued in cross progeny of rib-1(ok556) hermaph-
rodites and wild-type males (data not shown), indicating that
either maternal or zygotic rib-1 activity is sufficient for
viability.To determine if HSPG synthesis is necessary for pharyngeal
morphogenesis, we examined the pharynxes of rib-1(ok556), rib-
2(qa4900), and rib-2(tm710) mutants. Maternally depleted rib-1
(ok556), rib-2(qa4900), and rib-2(tm710) animals that completed
body elongation exhibited incompletely elongated pharyngeal
isthmuses nearly identical to pyr-1, sqv-1, and sqv-8 mutants
(Figs. 7C, D and data not shown). Likewise, these maternally
depleted rib-1(ok556), rib-2(qa4900), and rib-2(tm710) mutants
exhibited defects in actin and intermediate filament organization
similar to pyr-1(cu8) (Figs. 5C and 6C; data not shown). In
comparison, the pharynxes of maternally rescued rib-1(ok556),
rib-2(qa4900), and rib-2(tm710) mutants appeared normal (data
not shown). Taken together, the similar phenotypes observed in
each of these mutants suggest that defective HSPG synthesis
underlies the defects in isthmus elongation.
pyr-1(cu8) genetically interacts with rib-1(ok556)
We hypothesize that pyr-1 functions upstream of HSPG
synthesizing enzymes by providing precursors of UDP-sugars
essential for HSPG synthesis. This hypothesis predicts that HSPG
synthesis defective mutants may be very sensitive to the levels of
pyrimidines and pyr-1 activity, and we indeed found that the rib-1
(ok556) phenotype was enhanced in a pyr-1(cu8) mutant back-
ground. Progeny of homozygous pyr-1(cu8) mutant hermaphro-
dites exhibited lethality and partially penetrant body elongation
defects, but they underwent normal hypodermal enclosure (Table
4), while progeny of heterozygous rib-1(ok556)/+hermaphrodites
were wild type [98.7% viable (n = 1183) compared to 98.3%
viable for N2 (n = 972)]. In comparison, progeny of pyr-1(cu8);
rib-1(ok556)/+ hermaphrodites exhibited enhanced embryonic
lethal phenotypes, in which the number and appearance of
unenclosed and partially elongated embryos was nearly identical
to those observed in progeny of rib-1(ok556) homozygotes (Table
4). This enhanced phenotype argues that, while one rib-1(+) allele
provides sufficient maternal activity for normal HSPG synthesis
and development when pyrimidine pools are high, a single
maternal rib-1(+) allele is insufficient for HSPG synthesis when
pyrimidine pools are reduced.
We next examined the progeny of pyr-1(cu8); rib-1(ok556)
homozygotes and found these animals exhibit similar pheno-
types to the progeny of rib-1(ok556) single mutants (Table 4).
Table 5
GAG disaccharides levels in pyr-1 and rib-1 mutants
Wild-type (N2)
pmol/mg (%)
pyr-1 (cu8)
pmol/mg (%)
rib-1(ok556)/+ a
pmol/mg (%)
Heparan sulfate
(n = 3)
49 ± 0.7 (100) 44 ± 1.2 (90) 30 ± 0.3 (61)
Chondroitin
(n = 2)
7058 ± 195 (100) 8913 ± 393 (126) 10,618 ± 473 (150)
GAGs obtained from these worms were analyzed by digestion with
chondroitinase or a mixture of heparitinases followed by anion-exchange
HPLC as described in Materials and methods. Values are expressed as pmol of
disaccharide per mg of dried homogenate of these worms. Numbers in
parentheses represent % yields of the chondroitin or heparan sulfate
disaccharides, taking the respective values for disaccharides from the N2
worms (wild-type) as 100%. (n) Equals the number of replicates for each
experiment.
a Full genotype is rib-1(ok556)/nT1.
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that elongated and hatched was similar to rib-1(ok556) single
mutants (Fig. 7E), and, while the number of unenclosed
embryos was increased moderately, no novel phenotypes were
observed. These phenotypes suggest that pyr-1 and rib-1
function in a single pathway promoting pharyngeal isthmus
elongation.
Heparan sulfate and chondroitin levels are altered in rib-1
(ok556) and pyr-1(cu8) mutants
We directly measured the amount of heparan sulfate and
chondroitin GAGs in strains bearing rib-1(ok556) and pyr-1
(cu8) mutations by HPLC following heparan lyase or
chondroitinase digestion (Mizuguchi et al., 2003), and found
that they differ from those in wild-type animals (Table 5). A
strain heterozygous for rib-1(ok556) exhibited strongly
decreased levels of heparan sulfate disaccharides and increased
chondroitin disaccharides. pyr-1(cu8) mutants also exhibited
decreased heparan sulfate GAGs and increased chondroitin
GAGs, although GAG levels were less strongly affected than in
the rib-1(ok556) mutant strain. While the change in chondroitin
was unexpected, comparable increases were observed in rib-2
(qa4900) mutants (Morio et al., 2003), and an analogous
increase in heparan sulfate was observed in sqv-5(RNAi)
animals deficient in chondroitin synthase (Mizuguchi et al.,
2003), suggesting that levels of heparan sulfate and chondroitin
are interdependent in vivo. Nevertheless, these results indicate
that GAG levels are altered in rib-1(ok556) and pyr-1(cu8)
mutants.
Discussion
pyr-1 and proteoglycan synthesis mutants exhibit similar
defects in pharyngeal morphogenesis
pyr-1 mutants exhibit maternal effect lethality, defects in
body elongation, and defects in pharyngeal morphogenesis. The
actin and intermediate filaments in the pharyngeal muscles and
marginal cells making up the isthmus are disorganized,suggesting a link between pharyngeal isthmus elongation and
cytoskeletal organization. Our finding that pyr-1 encodes CAD
and the fact that pyr-1 phenotypes can be rescued by exogenous
pyrimidines indicate that the basis for these phenotypes is an
insufficient pyrimidine pool. However, pyrimidines are used for
a variety of essential purposes in cells, including the synthesis of
nucleic acids and the synthesis of sugar nucleotides for poly-
saccharide assembly (Huang and Graves, 2003). How do de-
creased pyrimidine pools have specific effects on development?
Pyrimidine nucleotides are synthesized by two alternative
biochemical pathways, and the nucleotides produced by these
pathways are used differently [reviewed in (Anderson and
Parkinson, 1997; Huang and Graves, 2003)]. The de novo
synthesis pathway requires CAD and is believed to contribute to
a cytoplasmic UTP pool preferentially used for nucleotide sugar
and polysaccharide synthesis, while the salvage pathway
producing pyrimidine nucleotides from uridine is believed to
contribute to a nuclear pool of UTP preferentially used for
nucleic acid synthesis (Pels Rijcken et al., 1993; Slingerland et
al., 1995). Mutants defective in PYR-1/CAD are therefore likely
to primarily affect polysaccharide synthesis by decreasing the
cytoplasmic UTP pool. Consistent with this, pyr-1 mutants do
not exhibit profound defects in cell division and early embryonic
development found in mutants with widespread defects in DNA
or RNA synthesis (Encalada et al., 2000; Han et al., 2003;
Kaltenbach et al., 2000; Walker et al., 2001). pyr-1mutants also
do not resemble those mutants affecting enzymes involved in N-
linked glycosylation or O-linked glycosylation of proteins other
than proteoglycans (Wang et al., 2005). In comparison, several
mutants defective in proteoglycan synthesis exhibit maternal
effect lethality and pharyngeal defects similar to those found in
pyr-1mutants. These include sqv-1 and sqv-8mutants, defective
in synthesis of both CPGs and HSPGs, as well as rib-1 and rib-2
mutants, defective in HSPG synthesis. These common pheno-
types strongly suggest that altered proteoglycan synthesis
underlies the pharyngeal abnormalities seen in all of these
mutants. Consistent with this hypothesis, we observed a strong
genetic interaction between pyr-1(cu8) and rib-1(ok556) muta-
tions, suggesting that HSPG synthesis is crucially dependent on
de novo pyrimidine synthesis.
Indeed, we did find that heparan sulfate and chondroitin
levels were altered in pyr-1(cu8) and rib-1(ok556) mutants.
These levels were less severely affected in pyr-1(cu8) mutants
than in rib-1(ok556), suggesting pyr-1 does not have a global
effect on proteoglycan synthesis. Rather, that pyr-1 loss may
affect synthesis of a small number of proteoglycans synthesized
at high levels during the short period of isthmus elongation.
While heparan sulfate levels were reduced in pyr-1 and rib-1
mutants, the chondroitin levels were unexpectedly increased.
Thus, the defects in these mutants could result from altered
levels of either or both of these proteoglycan types. However,
we suggest that decreased HSPG levels are the primary cause of
pharyngeal defects in all of these mutants, as similar pharyngeal
defects are observed in sqv mutants, which have reduced rather
than increased CPG levels (Bulik et al., 2000).
What is the function of HSPGs in pharyngeal isthmus
elongation? We anticipate possible roles either as structural
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mediators of cell signaling necessary for isthmus elongation. C.
elegans contains a single gene encoding the major extracellular
HSPG core protein UNC-52/perlecan (Rogalski et al., 1993),
and UNC-52 protein accumulates in the pharyngeal basement
membrane beginning at the 2-fold stage when isthmus
elongation occurs (Mullen et al., 1999). unc-52 null mutants
have defects in isthmus elongation (Mullen et al., 1999), but, as
these mutants also exhibit penetrant defects in body elongation,
we do not know if the pharyngeal defect is a direct effect UNC-
52 loss in the pharynx. UNC-52 could play a structural role in
the pharyngeal basement membrane or a role in cell signaling as
has been observed during gonad morphogenesis (Merz et al.,
2003). However, it is not clear that UNC-52 is modified with
heparan sulfate GAGs in the pharyngeal basement membrane,
as these HSPGs have not yet been detected in this tissue
(Minniti et al., 2004; Franks and Okkema, unpublished). C.
elegans also contain single genes encoding the major HSPG cell
surface core proteins GPN-1/glypican and SDN-1/syndecan.
GPN-1 protein localization has not yet been described, and gpn-
1(ok377) mutants have normal pharyngeal morphology (D.
Franks and P. Okkema, unpublished). SDN-1 is present in the
nerve ring surrounding the pharyngeal isthmus, as well as the
nerve cords and the vulva, and it is modified with heparan
sulfate GAGs in these tissues (Minniti et al., 2004). sdn-1
mutants are viable and in preliminary experiments we have
observed a low penetrance isthmus elongation defect (Franks
and Okkema, unpublished). SDN-1 could potentially mediate
signals from the nerve ring to promote isthmus elongation. As
SDN-1 is not the only HSPG in the nerve ring (Minniti et al.,
2004), there may be additional HSPGs present in this tissue with
partially redundant functions.
Comparison of the pyr-1 mutant to others affecting pharyngeal
morphogenesis
A number of mutants affecting pharyngeal morphogenesis
have been previously identified in C. elegans. Early steps
leading to formation of an epithelial tube connected the exterior
of the worm are defective in mutants affecting a variety of
chromatin regulatory proteins and the UBC-18 ubiquitin
conjugating enzyme (Fay et al., 2003). Many of these chromatin
regulatory mutants have been previously identified based on a
synthetic multivulva phenotype (synMuv) (reviewed in Fay and
Han, 2000), and they also exhibit redundancy in the pharynx
(Fay et al., 2003). A later step in pharyngeal morphogenesis is
defective in mutants affecting the HEX family homeobox gene
pha-2 (Avery, 1993; Mörck et al., 2004). These mutants exhibit
defects in pharyngeal isthmus elongation and contain nuclei
inappropriately positioned in the isthmus. These phenotypes
arise between the 2- and 3-fold stages of embryogenesis and are
believed to result from a mis-specification of isthmus cell fate
(Mörck et al., 2004).
pyr-1mutants share the thick isthmus morphology with pha-
2 mutants, although they do not contain mispositioned nuclei in
the isthmus. However, it is possible that pyr-1 function overlaps
that of pha-2. Vertebrate HEX gene expression is regulated bysignaling pathways that involve HSPG function (i.e., Wnt, FGF,
and BMP) (Bischof and Driever, 2004; Foley and Mercola,
2005; Ho et al., 1999; Zhang et al., 2004), and we are currently
examining the relationship between the pyr-1 and pha-2 mutant
phenotypes.
CAD function and pyrimidine metabolism in other organisms
The best characterized mutants affecting CAD are the
classical Drosophila r mutants, which result in abnormal
wings, female sterility, and maternal effect lethality (Fausto-
Sterling and Hsieh, 1976; Morgan et al., 1925; Rawls and
Fristrom, 1975; Segraves et al., 1984). r mutants also exhibit
zygotic lethality and defects in leg and eye-antennal disc
derivatives when cultured on pyrimidine free media (Falk,
1977). r wing defects are accompanied by a decrease in the
number and size of individual cells in the wing, and an increase
in the levels of the polysaccharide chitin (Fausto-Sterling and
Hsieh, 1976). However, the mechanistic basis of wing defects in
r mutants is not clearly understood. r activity is necessary for
wing development in pupa, but not during proliferation of the
wing disc cells in larvae (Falk, 1977), suggesting that cell
division defects may not be the only cause underlying the r
mutant wing phenotype.
The zebrafish perplexed mutation affects CAD and results in
defects in cell proliferation and differentiation in the developing
retina, as well as morphogenetic defects in the fins and jaw
(Link et al., 2001; Willer et al., 2005). The jaw defect in
particular is believed to result from insufficient UDP-dependent
protein glycosylation, as a mutation affecting UDP-glucuronic
acid decarboxylase phenocopies this defect (Willer et al., 2005).
This enzyme synthesizes UDP-xylose essential for initiating
GAG attachment to proteoglycans, and the jaws of both per-
plexed mutants and UDP-glucuronic acid decarboxylase
mutants show strongly decreased alcian blue staining of
proteoglycans in jaw cartilage. In C. elegans, UDP-glucuronic
acid decarboxylase is encoded by sqv-1 (Hwang and Horvitz,
2002b), one of the genes required for isthmus elongation
similarly to pyr-1. The fact that CAD mutants share phenotypes
with proteoglycan synthesis defective mutants in both zebrafish
and C. elegans is striking and suggests that the downstream
metabolism of de novo synthesized pyrimidines may be similar
in distantly related organisms.
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